Alvotech stock has dropped despite strong fundamentals and rapid sales growth. Read about ALVO's projected revenue, debt ...

Ivers-Lee’s assembly and packaging capabilities will be integrated into Alvotech's Technical Operations division.

Linda Jónsdóttir Linda Jonsdottir, Alvotech's new Chief Financial Officer REYKJAVIK, ICELAND (July 10, 2025) — Alvotech ...

Alvotech acquires Swiss packaging firm Ivers-Lee to boost biosimilar production capacity ahead of three 2025 launches.

Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...

Joel Morales, who has served as CFO of Alvotech since 2020, based in the U.S., has decided to step down. He will continue supporting Alvotech in an advisory capacity to ensure a smooth transition.

Alvotech and Advanz Pharma announce positive EMA opinion for AVT06, a biosimilar to Eylea®, advancing access for eye disorder treatments in Europe.

An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane ...

Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that ...

Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred ...

--Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as Chief ...